FDA Law
JANUARY 4, 2023
Brevig, Senior Regulatory Device and Biologics Expert — On December 7, 2022, FDA’s Center for Biologics Evaluation and Research (CBER) and the Office of Tissues and Advanced Therapies (OTAT) held a town hall to answer questions related to cell therapy and tissue-engineered products chemistry, manufacturing, and contrÂÂols (CMC).
Medical Xpress
JULY 1, 2025
Im hopeful that the genomic information from this and future studies will guide choices of chemotherapies, and their adoption in clinical practice." We are constantly on the lookout for better ways of giving therapy and minimizing the side effects of toxic, systemic treatments. "Im
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medical Xpress
JUNE 16, 2025
The goal is to support clinical trials and bring in another $50 million in private investment to help ibogaine win approval from the U.S. Other states like Oregon and Colorado have already launched legal clinics using psilocybin, the compound found in mushrooms, The Times reported. Food and Drug Administration (FDA).
Medical Xpress
JUNE 16, 2025
Consider supporting Science Xs mission by getting a premium account.
Medical Xpress
JUNE 8, 2025
Long-term effects of pain in early life We collected data on the number of procedures, clinical exposures and sucrose doses from three NICUs across Canada. But as the findings from our Canadian study show, we urgently need research to improve long-term health outcomes for children born prematurely.
Medical Xpress
JUNE 7, 2025
In clinical trials, no participants who received the injection acquired HIV. The long-acting shot may increase PrEP uptake, especially among those preferring injections over daily pills, but challenges remain in reaching underserved populations and ensuring equitable access. Consider supporting Science Xs mission by getting a premium account.
Expert insights. Personalized for you.
59 
Let's personalize your content